Insights from 2023 EHA® Annual Meeting


 

2023 EHA® Insights: "Matching-Adjusted Indirect Comparison of Zanubrutinib vs. Ibrutinib in R/R MZL"

51 views
July 6, 2023
0 Comments
Login to view comments. Click here to Login